Impact Biomedical furnishes investor presentation; no specific financial updates disclosed

IMPACT BIOMEDICAL INC.

COO Mark Suseck began delivering investor presentations on November 4, 2024.
Presentation slide deck furnished as Exhibit 99.1; no new financial data or guidance in the filing.
Company does not assume obligation to update the presentation information.
No material operational metrics, revenue, or earnings figures provided in the 8-K.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.